Biomedical Entrepreneur Alfred Mann

Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.

LoneStar Heart, Inc. is an early-stage biomedical company developing new therapies to preserve and restore adequate heart function in patients with Congestive Heart Failure (CHF)... Learn more.


The company's product line includes three types of EtO sterilizers (Anprolene, EOGas and Sterijet), with their associated chemical and biological sterilization monitors... Learn more

Using the patient's own bone marrow, researchers apply zinc finger nucleases to generate stem cells lacking the crucial gene, CCR5, that normally lets HIV into the key immune cells it destroys. These cells are infused into the patient to fight off the HIV virus... Read more

The company received additional funding after successful completion of non-human primate studies to further advance HemaMax as a radiation counter-measure: Read more

VQ OrthoCare Inc., an Irvine maker of joint braces and other orthopedic support devices, is looking to grow as an alternative to surgeries and drugs for an aging population. The company's products are worn to support knees, arms and ankles. It also makes devices that send a small electrical signal to the body to stimulate bone growth. Another device uses electrotherapy to block pain signals from getting to the brain. Unlike a lot of local medical device companies, VQ's products aren't made to be used during surgery or be implanted in the body... Read more

In order to close the widening gap between the rapid expansion of biomedical discoveries and the application of those discoveries in a clinical environment, UC Irvine School of Medicine developed the program in partnership with UC Irvine Extension to equip medical industry professionals with the academic knowledge, technical skill and critical thinking ability necessary to understand and evaluate clinical studies and translate clinical research into practice. Available for the first time this fall quarter, registration is currently open... Click here for more info

In 2007, Congress passed a law dramatically expanding the FDA's power by giving it the ability to force companies to develop Risk Evaluation and Mitigation Strategies (REMS) to make sure patients are aware of any drug risks and that misuse is avoided. REMS were originally developed for drugs that cause birth defects, like Roche's acne medicine Accutane or Celgene's cancer pill Thalomid, also known as thalidomide. But now they have become the new hurdle for companies hoping to market medicines... Read more

Due to China's policy on enhancing fast track development of the bio-industry and as well as health reform entailing national healthcare service by 2020, China's medical device market is expected to grow to US$20.6 billion in 2010 and is fast becoming one of the world's largest markets. The International Medical Device, Equipment and Supplies tradeshow will be held in Hong Kong 3-5 November 2010. Allied Intrade Inc. will be bringing a private business delegation to Hong Kong to attend this trade show, industry networking events, pre-arrange private business collaboration meetings, exclusive tour the Medical Device Industrial City in Dongguan and the Hong Kong Science and Technology Park. For further information, please contact Caroline Cheung at caroline@alliedintrade.com

Arrowhead's Executive Chairman of the Board of Directors R. Bruce Stewart said, "Dr. Ferrari is a scientific visionary and has been a strong proponent of our efforts at Arrowhead. He brings a wealth of knowledge from his leadership roles at influential hospitals, academia and institutions to help us build-out our nanomedicine portfolio...Read more 


STAAR's reemergence as a growing leader in the ophthalmic marketplace has enabled us to attract two experienced executives to play key roles in the successful execution of our strategy to achieve sustainable profitable growth in our core technologies, ICLs and IOLs," said Barry G. Caldwell, President and CEO... Read more

• Executive Director

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio